Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in IMNN — Imunon, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to IMNN Full portfolio

Position in IMNN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,948
-$3,876 QoQ
Shares Held
3,342
0.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 23 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in IMNN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. IMNN ranks #334 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in IMNN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,948 3,342
2026-03-31 $9,824 3,342
2025-12-31 $13,098 3,438
2025-09-30 $17,442 3,400
2025-06-30 $33,458 41,823
2024-03-31 $119 73
2023-12-31 $48 72
2023-09-30 $66 68
2023-06-30 $85 66
2023-03-31 $63 51
2022-12-31 $64 48
2022-09-30 $78 47
2022-06-30 $88 48
2022-03-31 $177 35